SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Filings re: Registrant of ‘10-K’ Filing 1558370-20-1571


        

705  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
-K to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   36   ·  All     
Bottom



        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
  7:34am Adaptimmune Therapeutics plc      8-K:5       5/14/24   10:218K                                   Toppan Merrill/FA        
 4/22/24  Adaptimmune Therapeutics plc      ARS        12/31/23    1:2.6M                                   Toppan Merrill/FA        
 4/12/24  Adaptimmune Therapeutics plc      8-K:1,9     4/10/24   11:179K                                   Toppan Merrill Bridge/FA 
 4/11/24  Adaptimmune Therapeutics plc      DEF 14A     5/14/24   11:6M                                     Toppan Merrill/FA        
  4/2/24 New Enterprise Assocs 14, L.P.    SC 13D/A     4/2/24    1:385K Adaptimmune Therapeutics plc      Go2 EDGAR SOLUTIONS… /FA 
          Anthony A. Florence, Jr.³
          Forest Baskett³
          Mohamad H. Makhzoumi³
          Nea 14 GP, Ltd.³
          Nea 16 GP, LLC³
          Nea Partners 14, L.P.³
          NEA Partners 16, L.P.³
          New Enterprise Associates 16, L.P.³
          Patrick J. Kerins³
          Scott D. Sandell³
  4/1/24  Adaptimmune Therapeutics plc      PRE 14A     5/14/24   12:6M                                     Toppan Merrill/FA        
 3/26/24  EcoR1 Capital, LLC                3          10% Owner²  1:5K   Adaptimmune Therapeutics plc      Shartsis Friese LLP      
 3/26/24  EcoR1 Capital, LLC                SC 13G/A               1:49K  Adaptimmune Therapeutics plc      Shartsis Friese LLP      
 3/18/24  Piccina Cintia                    4          Officer²    1:7K   Adaptimmune Therapeutics plc      Toppan Merrill/FA        
  3/6/24  Adaptimmune Therapeutics plc      10-K       12/31/23  131:16M                                    Toppan Merrill Bridge/FA 
  3/6/24  Adaptimmune Therapeutics plc      8-K:2,9      3/6/24   11:494K                                   Toppan Merrill Bridge/FA 
 2/27/24  Adaptimmune Therapeutics plc      8-K:5,9     2/26/24   12:335K                                   Toppan Merrill Bridge/FA 
 2/16/24  Adaptimmune Therapeutics plc      8-K:3       2/16/24   10:144K                                   Toppan Merrill Bridge/FA 
 2/14/24  Long Focus Capital Mgmt, LLC      SC 13G/A               2:139K Adaptimmune Therapeutics plc      Borer Fin’l Comms, Inc.  
          A. Glenn Helmers³
          Condagua, LLC³
          John B. Helmers³
          Long Focus Capital Management, LLC³
          Long Focus Capital Master, Ltd.³
 2/14/24  Baker Bros. Advisors LP           SC 13G/A               1:87K  Adaptimmune Therapeutics plc      Toppan Merrill/FA        
          Baker Bros. Advisors (GP) LLC³
          Felix J. Baker³
          Julian C. Baker³
 1/31/24  Adaptimmune Therapeutics plc      8-K:8,9     1/31/24   11:188K                                   Toppan Merrill Bridge/FA 
 1/30/24  EcoR1 Capital, LLC                SC 13G                 1:49K  Adaptimmune Therapeutics plc      Shartsis Friese LLP      
 1/29/24  Baillie Gifford & Co.             SC 13G/A               1:11K  Adaptimmune Therapeutics plc                               
 1/17/24  Rawcliffe Adrian                  4          Dir.,Off.²  1:8K   Adaptimmune Therapeutics plc      Toppan Merrill/FA        
 1/17/24  Norry Elliot                      4          Officer²    1:11K  Adaptimmune Therapeutics plc      Toppan Merrill/FA        
____________
 †  The Filing’s time of SEC acceptance (U.S. Eastern Time).  The SEC’s Filings System is “open” Monday through Friday from 6am
Six o'clock emoji
to 10pm
Ten o'clock emoji
ET
.
Because the SEC “closes” at 5:30pm
Five-thirty emoji
ET
, most subsequently-accepted Filings won’t be released to the public until sometime after 6am
Six o'clock emoji
ET
the next day.
 ‡  A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm
Five-thirty emoji
ET
.  The legal “Filed As Of” date may be the next, or another, day.
 ¹  Filing/Form Types: 
Type emoji
-K
  3    Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
  4    Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  10-K    Annual Report — Form 10-K.
  ARS    Annual Report to Security Holders.
  DEF 14A    Definitive Proxy Statement — Schedule 14A.
  PRE 14A    Preliminary Proxy Statement — Schedule 14A.
  SC 13D    Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
  SC 13G    Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
  /A  Amendment to, or Amended version of, a previous Filing of this Type.
 ²  Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
 ³  Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.
 
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   36   ·  All     
Top



        


Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 10:00:29.7pm ET